Louise Moon
Person
Louise Moon is an audio professional associated with Bloomberg Audio Studios. She has contributed to the Stock Movers Report, introducing hosts Lizzie Burden and Stephen Carroll.
What Louise Moon has said on podcasts
280 statements
HelloFresh’s outlook confirms soft trends and implies future weakness.
“it follows soft trends, confirms these soft trends, infers weakness ahead”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 0:57
HelloFresh shares reached a record low and fell as much as 13%.
“So shares hit a record low this morning. They're down as much as 13% this morning.”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 1:03
UBS may face stricter capital rules in Switzerland.
“they're facing the possibility of stricter capital rules at home in Switzerland”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 1:25
The endorsed Swiss plan would force UBS to hold more equity capital.
“would force UBS to hold more equity capital”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 1:34
The plan would require UBS to hold an additional $16 billion in equity capital.
“it would require it to hold an extra $16 billion, um, in that capital”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 1:38
UBS shares rose about 2.5% following the jurisdiction report.
“but its shares have risen on the back of that, up, um, about 2.5% this morning”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 2:06
Nanexa’s technology could reduce obesity injections to one every few months.
“technology that could mean that patients need just one obesity shot every few months rather than the more regular occurrence now”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 2:28
Nanexa shares jumped 161% after the Novo Nordisk deal.
“Nanexa shares obviously jumped. This is a big deal for them. They've jumped 161%.”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 2:35
The Nanexa deal is unlikely to trigger Novo Nordisk’s price in the short term.
“it's unlikely to be a short-term trigger for their price”
Open the episode · UBS Rises, Novo Climbs, HelloFresh PlummetsListen at 2:53
Vistry shares fell 10%, extending their losses for the year.
“Shares fell 10%, extending losses that we've already seen this year.”
Open the episode · Vistry Drops, Asos Rises, Christian Dior SurgesListen at 1:55
ASOS shares rose almost 8% to their highest level in three years.
“Their shares risen almost 8% in morning trading, the highest level in 3 years.”
Open the episode · Vistry Drops, Asos Rises, Christian Dior SurgesListen at 2:28
ASOS is increasingly shifting from restructuring toward profitable growth.
“analysts are saying that these results are showing that ASOS is increasingly shifting from a restructuring company towards profitable growth.”
Open the episode · Vistry Drops, Asos Rises, Christian Dior SurgesListen at 3:08
Dior shares rose as much as 19%.
“shares are rising as much as 19%.”
Open the episode · Vistry Drops, Asos Rises, Christian Dior SurgesListen at 3:26
The Arnault family would have to offer cash for all unowned Dior shares.
“they would have to make a tender offer in cash for all Dior shares that they don't own.”
Open the episode · Vistry Drops, Asos Rises, Christian Dior SurgesListen at 3:49
Kingfisher raised full-year guidance beyond expectations
“it's lifted its full-year guidance beyond expectations”
Open the episode · Kingfisher Soars, Roche's Shot, Ericsson's SlipListen at 0:58
Kingfisher’s first-half earnings beat estimates
“their first half earnings. Those beat estimates”
Open the episode · Kingfisher Soars, Roche's Shot, Ericsson's SlipListen at 1:05
Roche’s highest-dose obesity shot reduced average body weight 15.5%
“those who received the highest dose lost an average of 15.5% of their body weight in that trial”
Open the episode · Kingfisher Soars, Roche's Shot, Ericsson's SlipListen at 2:40
Morgan Stanley downgraded Ericsson to underweight
“Morgan Stanley this morning have downgraded it to underweight from equal weight”
Open the episode · Kingfisher Soars, Roche's Shot, Ericsson's SlipListen at 3:11
Anticipated 5G network spending failed to materialize
“There was anticipated spending on 5G networks that failed to materialize”
Open the episode · Kingfisher Soars, Roche's Shot, Ericsson's SlipListen at 3:42
JD Sports expects difficult trading to continue in the second half.
“they're expecting this tough trading to continue in the second half”
Open the episode · JD Sports Falls, Aegon Down, Trainline DropsListen at 2:03
Trainline customers could receive compensation if the company broke drip-pricing law.
“if they're found to have broken the law, then customers could get compensation from trainline”
Open the episode · Trainline Dips, Smith & Nephew Falls, Straumann DropsListen at 1:37
Trainline shares fell 17%, their largest decline in five years.
“Shares fell 17% this morning, so the most in five years”
Open the episode · Trainline Dips, Smith & Nephew Falls, Straumann DropsListen at 1:43
Smith & Nephew’s CFO departure will create uncertainty about its financial outlook.
“his departure will raise questions about the company's financial outlook”
Open the episode · Trainline Dips, Smith & Nephew Falls, Straumann DropsListen at 3:22
Straumann shares fell as much as 9%, their largest one-year decline.
“shares down as much as 9% the most in a year this morning”
Open the episode · Trainline Dips, Smith & Nephew Falls, Straumann DropsListen at 3:49
Straumann’s CEO departure is causing its shares to decline.
“this news is really overshadowing things and causing those shares to drop”
Open the episode · Trainline Dips, Smith & Nephew Falls, Straumann DropsListen at 4:10
Hugo Boss shares rose nearly 2% after Frasers Group increased its stake.
“shares higher this morning, just over 1%. Just under 2% higher.”
Open the episode · Frasers Group Up, Royal Unibrew Drops, OXB DownListen at 1:11
Royal Unibrew shares fell more than 9%, their largest decline since April.
“shares falling just over 9%. That's the most since April.”
Open the episode · Frasers Group Up, Royal Unibrew Drops, OXB DownListen at 2:58
Oxford Biomedica cut its full-year revenue and profitability guidance.
“they cut their full year revenue and profitability guidance.”
Open the episode · Frasers Group Up, Royal Unibrew Drops, OXB DownListen at 4:05
Copper prices are approaching record highs.
“Copper is rising towards record highs.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 1:14
Gold prices are rising.
“gold is also rising.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 1:26
Mining companies are performing strongly overall.
“So overall strong performance for miners”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 1:39
AstraZeneca is stopping a trial of an experimental cancer drug.
“they're stopping a trial of a experimental cat cancer drug.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 1:58
AstraZeneca reported positive late-stage studies for an approved lung-cancer drug.
“positive late late stage studies for an already approved drug to do also with lung cancer.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 2:40
Argenx shares rose by as much as 10%.
“shares up as much as 10%.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 3:00
Argenx reported a large, successful trial for its blockbuster drug.
“it reported its latest large and successful trial for its blockbuster drug.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 3:02
Aviva expects to meet its longer-term targets.
“they also say they're very confident in hitting their longer term targets”
Open the episode · Aviva Rises, DFDS Surges, GB Group SinksListen at 1:13
GB Group lowered its full-year revenue guidance.
“they've lowered their full year revenue guidance”
Open the episode · Aviva Rises, DFDS Surges, GB Group SinksListen at 3:09
Adyen expects full-year revenue growth of up to about 23%.
“they now expect new revenue growth of up to about 23%”
Open the episode · Adyen Soars, Maersk Jumps, Entain WaversListen at 0:51
Adyen’s acquisitions are boosting its revenue forecast.
“that's paying off and that's what's boosting their revenue forecast”
Open the episode · Adyen Soars, Maersk Jumps, Entain WaversListen at 1:17
Maersk has raised its full-year guidance again.
“they've raised their full year guidance again”
Open the episode · Adyen Soars, Maersk Jumps, Entain WaversListen at 1:47
ABN Amro reported strong results and raised its net interest income outlook.
“Second quarter results this morning pretty strong. So profits beat expectations. They raised the outlook for net interest income.”
Open the episode · ABN Amro Jumps, Vestas Surges, TUI FallsListen at 0:59
ABN Amro shares gained about 6% and had risen about 35% year-to-date.
“shares gaining up about 6 or so percent this morning. They have already risen about 35% this year.”
Open the episode · ABN Amro Jumps, Vestas Surges, TUI FallsListen at 1:08
ABN Amro’s cost controls, AI use, and acquisition have benefited the company.
“the CEO has been prioritizing cost controls. So things like job cuts included in that efficiency. So also using AI and they have and also acquisition. And so this has been benefiting ABM Ambro”
Open the episode · ABN Amro Jumps, Vestas Surges, TUI FallsListen at 1:17
Vestas raised its full-year profit outlook.
“they raised their full year profit outlook”
Open the episode · Vestas Surges, Hermes Drops, Kingspan JumpsListen at 1:17
Vestas announced a €400 million share buyback.
“a new 400 million euro buyback”
Open the episode · Vestas Surges, Hermes Drops, Kingspan JumpsListen at 1:20
Vestas wind-turbine orders rose 40%.
“total orders for those rose 40%”
Open the episode · Vestas Surges, Hermes Drops, Kingspan JumpsListen at 1:26
Vestas’s price increases have not deterred turbine orders.
“increasing their prices. But that hasn't seemed to deter orders.”
Open the episode · Vestas Surges, Hermes Drops, Kingspan JumpsListen at 1:48
Vestas shares rose as much as 19% that morning.
“Shares up as much as 19% this morning”
Open the episode · Vestas Surges, Hermes Drops, Kingspan JumpsListen at 1:55
Vestas’s price increases have not reduced its turbine orders, which continue climbing.
“they have increased prices. But that obviously hasn't impacted orders. Those orders still climbing”
Open the episode · ABN Amro Jumps, Vestas Surges, TUI FallsListen at 2:18
Chinese demand for luxury goods is changing.
“Demand in China is changing.”
Open the episode · Vestas Surges, Hermes Drops, Kingspan JumpsListen at 2:54
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
30 episodes featuring Louise Moon

Stock Movers
European stocks split as UBS weighs capital rules and HelloFresh cuts forecasts
The episode shows how regulatory uncertainty, weaker guidance, and drug-development deals are driving sharply different outcomes across European markets.
Sep 25, 2026 · 4 min

Stock Movers
Dior surges as Vistry stumbles and ASOS regains momentum
The episode shows how corporate actions, housing weakness, and retailer performance are driving sharply different outcomes across European shares.
Sep 24, 2026 · 5 min

Stock Movers
Kingfisher lifts guidance as Ericsson loses analyst support
The episode contrasts a retailer gaining momentum from operational growth with a telecom equipment maker facing margin and demand concerns.
Sep 22, 2026 · 6 min

Stock Movers
European retailers and insurers absorb fresh market pressure
The episode shows how consumer strain, regulatory scrutiny, and uneven financial results can drive sharp moves across European companies.
Aug 20, 2026 · 7 min

Stock Movers
Regulatory scrutiny and exits rattle European stocks
The episode shows how a competition investigation and unexpected leadership changes can quickly undermine investor confidence in European companies.
Aug 19, 2026 · 5 min

Stock Movers
Frasers Group nears control of Hugo Boss as rivals stumble
The episode tracks three distinct market signals: a near-controlling stake in Hugo Boss, weak Royal Unibrew earnings, and a downgrade-driven fall for Oxford Biomedica.
Aug 18, 2026 · 7 min

Stock Movers
European miners rise as drug trials reshape pharma stocks
The episode connects commodity prices, clinical-trial risk, and drone regulation to sharp moves across European and technology-linked companies.
Aug 17, 2026 · 6 min

Stock Movers
Aviva beats forecasts as DFDS surges and GB Group slides
The episode shows how sharply different company updates can reshape European stock performance in a single trading session.
Aug 14, 2026 · 4 min

Stock Movers
Vestas lifts guidance as luxury stocks retreat
The episode shows how company-specific catalysts and sector-wide analyst pressure are driving sharply different outcomes across European equities.
Aug 12, 2026 · 7 min

Stock Movers
European earnings split the market between winners and losers
The episode shows how company-specific results and geopolitical tensions are producing sharply different outcomes across European stocks.
Aug 12, 2026 · 6 min

Stock Movers
Alcon rallies as Bellway and IWG face investor doubts
The episode shows how guidance, cash flow and demand signals can send European stocks in sharply different directions.
Aug 11, 2026 · 6 min

Stock Movers
Chip stocks rally as Aryzta falters and hiring steadies
The episode connects semiconductor momentum, bakery-sector weakness and early signs of stability in UK recruitment markets.
Aug 10, 2026 · 7 min

Stock Movers
WPP cuts costs as European stocks split on outlooks
The episode shows how company-specific decisions—from restructuring to lost contracts and acquisitions—are driving sharply different market reactions.
Aug 6, 2026 · 6 min

Stock Movers
European shares climb as retailers, miners and brewers beat expectations
The episode shows how upgraded guidance, stronger-than-expected earnings and emerging-market demand are moving major European stocks.
Aug 5, 2026 · 7 min

Stock Movers
European earnings reveal deep divides for HSBC, BP, and Smith & Nephew
The latest corporate earnings show how geopolitical friction and shifting US demand are creating stark winners and losers among Europe's largest companies.
Aug 4, 2026 · 5 min

Stock Movers
AstraZeneca drops on merger talks while airlines and shipping surge
This episode highlights how shifting energy costs, geopolitical shipping disruptions, and aggressive cross-border healthcare deals are rapidly reshaping European equity markets.
Aug 3, 2026 · 7 min

Stock Movers
European stocks swing as Universal Music plunges and Sainsbury's climbs
These sharp corporate moves reveal how high interest rates and changing consumer habits are forcing major European companies to restructure or face severe market penalties.
Jul 31, 2026 · 6 min

Stock Movers
European stocks jump as Reckitt and Kering post strong earnings
Strong quarterly reports from major European firms offer critical signals on consumer demand in Asia and the resilience of global commodity trading.
Jul 29, 2026 · 6 min

Stock Movers
Takeover bids and strong earnings push European stocks higher
This episode highlights the specific corporate catalysts driving European market gains, from private equity acquisitions to resilient telecom and pharmaceutical demand.
Jul 27, 2026 · 6 min

Stock Movers
Cloud growth boosts SAP while Sanofi dips on halted drug trial
Understanding these corporate shifts reveals the divergent health of Europe's tech, pharmaceutical, and engineering sectors amid shifting demand and consolidation.
Jul 24, 2026 · 6 min

Stock Movers
Novartis cancer drugs and UK defense signals spark European market rally
This episode highlights how corporate innovation in healthcare and shifting geopolitical defense spending are actively reshaping European market valuations.
Jul 21, 2026 · 4 min

Stock Movers
Nvidia stabilizes ahead of earnings while Prologis bids billions for Segro
This episode connects the dots between stabilizing tech valuations, massive industrial real estate consolidation, and signs of consumer fatigue.
Jul 20, 2026 · 7 min

Stock Movers
Supply pressures and US demand split European market performance
Understanding these divergent corporate updates reveals how localized supply chain pressures and regional consumer strength are actively reshaping European stock valuations.
Jul 14, 2026 · 5 min

Stock Movers
Legal victories and guidance resets trigger major swings in European stocks
Understanding the immediate market impact of legal rulings and corporate guidance updates is essential for navigating volatile European equity markets.
Jul 3, 2026 · 7 min

Stock Movers
European stocks diverge as PPHE plunges and Sodexo beats expectations
The stark divergence between PPHE's plunge and Sodexo's rise highlights how quickly corporate strategy shifts and earnings surprises can reshape European mid-cap valuations.
Jul 2, 2026 · 5 min

Stock Movers
Homebuilders rise as Volkswagen cuts costs and Zalando faces scrutiny
The episode contrasts investor optimism around UK housing with industrial restructuring at Volkswagen and regulatory risk at Zalando.
Jun 26, 2026 · 7 min

Stock Movers
EasyJet rejects Castlelake bid while HB Fuller acquires Advanced Medical Solutions
The latest corporate maneuvers highlight how European firms are navigating aggressive US buyout bids and shifting retail earnings.
Jun 25, 2026 · 5 min

Stock Movers
European markets shift as TKMS wins defense contract and SEGRO rejects bid
Major corporate maneuvers in Europe reveal how national defense decisions and high-stakes real estate bids are rapidly reshaping market valuations.
Jun 24, 2026 · 7 min

Stock Movers
Private equity targets Edenred as Evonik slashes German workforce
Corporate restructuring and aggressive private equity maneuvers are redefining the competitive landscape for major European employers and financial services.
Jun 18, 2026 · 4 min

Stock Movers
US-Iran peace deal drives down oil as activist targets Bunzl
Geopolitical breakthroughs and activist campaigns are rapidly shifting capital away from traditional energy giants and toward travel and AI infrastructure.
Jun 15, 2026 · 6 min
